Optical recording of neural signals evoked by greater superficial petrosal nerve stimulation in rat.
Electrical responses to greater superficial petrosal (GSP) nerve stimulation in a rat geniculate ganglion (GG) preparation were assessed by simultaneous multi-site-optical recording. The GG/GSP nerve preparations were dissected out and were stained with a voltage-sensitive dye (RH155). Application of depolarizing square pulses to the GSP nerve fibers using a suction electrode evoked optical (absorbance) signals that were recorded simultaneously from many contiguous regions using a 24 x 24 photodiode matrix array with 448 active elements. Those optical signals were observed along the left half area of the GSP nerve. As the distance from the site of stimulation increased, the optical signals appeared to conduct with increasing time-delay. From the relationship between the peak latency and distance, the conduction velocity was estimated to be about 0.4 m/s. Tetraethylammonium affected the duration of the optical signals, and the signals disappeared in solutions containing tetrodotoxin (TTX) or in Na(+)-deficient solutions. The optical signals evoked by the GSP nerve stimulation are considered to be due to the action potentials propagating along the GSP of unmyelinated axons.
Yanaura
M
M
Advanced Technology R & D Center, Mitsubishi Electric Corporation, Hyogo, Japan.
Yamada
S
S
Shiono
S
S
Nakashima
M
M
D000344:Afferent Pathways / Q000187:drug effects / Q000502:physiology; D000818:Animals; D004558:Electric Stimulation; D005073:Evoked Potentials, Somatosensory / Q000187:drug effects; D005260:Female; D005830:Geniculate Ganglion / Q000187:drug effects / Q000502:physiology*; D066298:In Vitro Techniques; D009431:Neural Conduction / Q000187:drug effects; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology*; D055095:Optics and Photonics; D026902:Potassium Channel Blockers; D051381:Rats; D017207:Rats, Sprague-Dawley; D012964:Sodium / Q000494:pharmacology; D026941:Sodium Channel Blockers; D013649:Taste / Q000502:physiology*; D019789:Tetraethylammonium; D013757:Tetraethylammonium Compounds / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
D026902:Potassium Channel Blockers; D026941:Sodium Channel Blockers; D013757:Tetraethylammonium Compounds; D013779:Tetrodotoxin; D019789:Tetraethylammonium; D012964:Sodium